# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001956827-25-000010
Filing Date
2025-03-24
Accepted
2025-03-24 17:00:26
Documents
193
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | abvx-20241231.htm iXBRL | 20-F | 12070117
2 | EX-1.1 | abivax-20xfxex11bylaws6feb.htm | EX-1.1 | 155555
3 | EX-2.1 | abivax-20xfxex21descriptio.htm | EX-2.1 | 225050
4 | EX-4.16 | abivax-20xfxex416summaryof.htm | EX-4.16 | 17203
5 | EX-4.17 | abivax-20xfxex417summaryof.htm | EX-4.17 | 10150
6 | EX-4.18 | abivax-20xfxex418summaryof.htm | EX-4.18 | 37729
7 | EX-11.1 | abivax-codeofmarketconduct.htm | EX-11.1 | 139786
8 | EX-12.1 | abivax-20xfxexhibit121ceo3.htm | EX-12.1 | 11548
9 | EX-12.2 | abivax-20xfxexhibit122cfo3.htm | EX-12.2 | 9766
10 | EX-13.1 | abivax-20xfxexhibit131ceo3.htm | EX-13.1 | 4462
11 | EX-13.2 | abivax-20xfxexhibit132cfo3.htm | EX-13.2 | 4527
12 | EX-15.1 | a4abivaxfy24_consentforf3v.htm | EX-15.1 | 11215
13 | EX-97.1 | abivax-20xfxex971incentive.htm | EX-97.1 | 48227
19 |  | abvx-20241231_g1.jpg | GRAPHIC | 119771
20 |  | abvx-20241231_g10.jpg | GRAPHIC | 20064
21 |  | abvx-20241231_g11.jpg | GRAPHIC | 11868
22 |  | abvx-20241231_g12.jpg | GRAPHIC | 30043
23 |  | abvx-20241231_g13.jpg | GRAPHIC | 36377
24 |  | abvx-20241231_g14.jpg | GRAPHIC | 53298
25 |  | abvx-20241231_g15.jpg | GRAPHIC | 112119
26 |  | abvx-20241231_g16.jpg | GRAPHIC | 31813
27 |  | abvx-20241231_g17.jpg | GRAPHIC | 30014
28 |  | abvx-20241231_g18.jpg | GRAPHIC | 21724
29 |  | abvx-20241231_g19.jpg | GRAPHIC | 31933
30 |  | abvx-20241231_g2.jpg | GRAPHIC | 93856
31 |  | abvx-20241231_g20.jpg | GRAPHIC | 124410
32 |  | abvx-20241231_g21.jpg | GRAPHIC | 124014
33 |  | abvx-20241231_g22.jpg | GRAPHIC | 164573
34 |  | abvx-20241231_g23.jpg | GRAPHIC | 148606
35 |  | abvx-20241231_g24.jpg | GRAPHIC | 20930
36 |  | abvx-20241231_g3.jpg | GRAPHIC | 31561
37 |  | abvx-20241231_g4.jpg | GRAPHIC | 22470
38 |  | abvx-20241231_g5.jpg | GRAPHIC | 42642
39 |  | abvx-20241231_g6.jpg | GRAPHIC | 36937
40 |  | abvx-20241231_g7.jpg | GRAPHIC | 33341
41 |  | abvx-20241231_g8.jpg | GRAPHIC | 24157
42 |  | abvx-20241231_g9.jpg | GRAPHIC | 24849
43 |  | image_0.jpg | GRAPHIC | 2000
44 |  | image_0b.jpg | GRAPHIC | 9503
45 |  | image_1.jpg | GRAPHIC | 4805
| Complete submission text file | 0001956827-25-000010.txt |  | 45704352

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | abvx-20241231.xsd | EX-101.SCH | 197464
15 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | abvx-20241231_cal.xml | EX-101.CAL | 129712
16 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | abvx-20241231_def.xml | EX-101.DEF | 998436
17 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | abvx-20241231_lab.xml | EX-101.LAB | 1316474
18 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | abvx-20241231_pre.xml | EX-101.PRE | 1264056
196 | EXTRACTED XBRL INSTANCE DOCUMENT | abvx-20241231_htm.xml | XML | 9646532

Mailing Address 7 BD HAUSSMANN PARIS I0 75009
Business Address 7 BD HAUSSMANN PARIS I0 75009 01 53 83 09 63
Abivax S.A. (Filer) CIK: 0001956827 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41842 | Film No.: 25764931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)